Kathleen Gallagher is chief executive of Atrium, which is developing siRNA therapies for genetic cardiomyopathies. As Novartis completed its $12 billion takeover of Avidity, a new cardiology-focused ...

[Editor's Note: Follow Khaleej Times live blog for the latest regional developments with the US-Israel-Iran ceasefire now in effect.] In a letter to UN officials, Bahrain has sought compensation from ...

It shared the details of the flights with the destinations which included places like London, Riyadh, Mumbai, Delhi, Hyderabad, Dubai, Jeddah and Kochi, among others.The airspace closure in the region ...

Bahrain has officially reopened its airspace, allowing flight operations to resume at Bahrain International Airport after a multi-day suspension triggered by escalating regional tensions.The closure, ...

Bahrain’s BAPCO Energies has confirmed that a tank fire broke out earlier on Sunday at one of its storage facilities, following a hostile Iranian drone attack. In a statement BAPCO Energies said: ...

A Bahraini official has said a Patriot air defence system intercepted an Iranian drone over a residential neighbourhood earlier this month, an account that apparently differs from the United States ...

MANAMA: The General Command of the Bahrain Defence Force announced that its air defence systems, since the onset of the hostile Iranian aggression, have intercepted and destroyed 139 ballistic ...

[Editor's Note: Follow Khaleej Times live blog amid US-Israel-Iran war for the latest regional developments.] Bahrain has relaxed some visa rules, in light of the current circumstances and the ...

Amazon's Bahrain data center was targeted by Iran for the company's support of "U.S. military and intelligence activities," the Fars News Agency said in a Telegram post. One of Amazon's facilities in ...

When Novartis agreed to buy RNA therapies developer Avidity Biosciences last fall, the companies said the plan was to spin out Avidity’s cardiology assets into a separate, publicly traded company.

A new biotech has taken flight as a result of Novartis’ red-hot $12 billion acquisition of muscular dystrophy specialist Avidity Biosciences. A spinout planned since that deal’s October announcement ...

ONE of the leading cinematic companies in the world had opened its latest operation in the kingdom’s newest mall, promising a whole new movie experience for all ages. Cinépolis, the world’s fourth ...